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Abstract
The metabolism of immune cells affects their function and influences host immunity. This review 
explores how immune cell metabolic phenotypes reflect biochemical dependencies, and highlights 
evidence that the metabolic state of immune cells and nutrient availability can both alter immune 
responses. The central importance of oxygen, energetics, and redox homeostasis in immune cell 
metabolism, and how these factors are reflected in different metabolic phenotypes, is also 
discussed. Linking immune cell metabolic phenotype to effector functions is important to 
understand how altering metabolism can impact the way in which immune cells meet their 
metabolic demands and affect the immune response in various disease contexts.
Introduction
All cells regulate their metabolism to support the biochemical demands of cell-type specific 
functions. The biochemical requirements of immune cells vary among different effector 
subsets, and change over the course of an immune response. Naïve lymphocytes must 
rapidly engage a proliferative metabolic program when foreign antigens are encountered 
(Johnson et al., 2016), macrophages must support an enzymatic program to process 
phagocytosed material (D. Park et al., 2011; Van den Bossche et al., 2017), and neutrophils 
must undergo a rapid respiratory burst to effectively destroy pathogens (El-Benna et al., 
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2016). In each case, cellular metabolism is adapted to allow each immune cell type to carry 
out its unique function and protect the host from pathogens and malignancy. Emerging data 
demonstrate that the metabolic state of immune cell populations is intimately tied to cellular 
differentiation and the activation of effector functions. Concurrently, immune cells encounter 
variations in nutrients, temperature, pH, and O2 as they traffic throughout the body, and 
these microenvironmental factors also impact metabolism and immune cell functions. 
Understanding how the interactions among immune cell biochemical requirements, cellular 
metabolic state, and nutrient availability interact to shape the immune response is critical to 
move beyond “metabolic phenotyping” to a more complete understanding of immune cell 
metabolism.
Metabolic phenotypes are often studied in cell culture, where nutrients are in excess and 
immune cells are separated from other tissue-resident cells. In recent years, disease models 
and clinical studies have begun to dissect the influence that local or systemic environmental 
factors have on the metabolism of tumor cells and immune cells, and there is growing 
evidence that systemic metabolic factors and local nutrient limitations at immune effector 
sites can be obstacles to both antimicrobial and anti-tumor immunity (Flint et al., 2016). 
Many cancer chemotherapies that target nucleotide metabolism also cause 
immunosuppression, increasing the risk of infection in cancer patients. Furthermore, the 
notion that cancer therapies might act, in part, by altering the tumor microenvironment and 
affecting immune cell function has generated interest in targeting immune cell metabolism 
to treat cancer (Chang and E. L. Pearce, 2016). It also raises the possibility that drugs 
targeting cancer metabolism might impair anti-tumor immunity, underscoring the 
importance of understanding the differences and similarities between immune and tumor cell 
metabolism and how this affects immune responses. This review will provide a framework 
for understanding immune cell metabolic phenotypes and attempt to connect metabolic 
phenotypes to the biochemical requirements of various immune cells.
Overview of Immune Cell Metabolic Phenotypes
Resting lymphocytes circulate in the blood, and cells in lymphoid tissues carry out 
surveillance for foreign antigens. Biosynthetic processes for these cells are minimal and they 
rely primarily on the mitochondrial oxidation of glucose and lipids to meet the energetic 
demands of survival and antigen surveillance. Homeostatic cues provided by molecules such 
as interleukin-7 that regulate T cell survival also are required for maintenance of this 
metabolic program (Jacobs et al., 2010). T cell antigen receptor stimulation in the presence 
of inflammatory co-stimulation leads to activation of the phosphatidyl-inositide-3-kinase 
(PI3K)/Akt/mTORC1 signaling pathway and induction of Myc, which promotes both 
aerobic glycolysis and increased glutamine metabolism, and drives increased lymphocyte 
numbers and size (Frauwirth et al., 2002; R. Wang et al., 2011). Glucose uptake increases 
and becomes limiting for T cell cytokine production and proliferation (Jacobs et al., 2008). 
Mitochondrial oxidative metabolism also increases, although to an extent that is relatively 
less than the increase in aerobic glycolysis, leading to the notion that activated T cells rely 
predominantly on aerobic glycolysis (Figure 1)(van der Windt et al., 2012; R. Wang et al., 
2011).
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Aerobic glycolysis is a characteristic feature of many rapidly dividing cells, including cancer 
cells and immune cells, in which glucose is fermented to lactate, even as sufficient O2 is 
present to support oxidative phosphorylation (OxPhos) (Roos and Loos, 1973; Vander 
Heiden et al., 2009; T. Wang et al., 1976). It has been proposed that the advantage of this 
metabolic phenotype in proliferating cells is to help meet the biochemical requirements of 
biosynthesis and allow cell duplication (Lunt and Vander Heiden, 2011). Indeed, aerobic 
glycolysis tracks with DNA synthesis in proliferating lymphocytes (T. Wang et al., 1976). 
Additionally, aerobic glycolysis may also play important roles in T cell effector function. 
The glycolytic intermediate phosphoenolpyruvate has been suggested to promote calcium 
signaling essential for T cell activation (Ho et al., 2015), and interferon-γ has been shown to 
be reliant on high rates of glucose metabolism through both transcriptional and translational 
regulation (Cham and Gajewski, 2005; Chang et al., 2013; Peng et al., 2016).
Activation of lymphocytes is followed by differentiation into cell subsets with specific 
effector or suppressor functions, and ultimately differentiation into long-lived memory cells. 
Where studied, each T cell subset has been found to display a unique metabolic program that 
supports the biochemical requirements of their distinct cellular functions (Beier et al., 2015; 
Gerriets et al., 2015; Michalek et al., 2011; Oestreich et al., 2014; Shi et al., 2011). In 
general, effector T cell subsets predominantly display a glycolytic phenotype, while the anti-
inflammatory regulatory T cell (Treg) subsets are characterized by the use of mitochondrial 
oxidative phosphorylation (Angelin et al., 2017). Under certain conditions, Treg cells have 
been observed to exhibit aerobic glycolysis downstream of PI3K/Akt/mTORC1 signaling 
(Zeng et al., 2013), but this metabolic phenotype is associated with reduced expression of 
the Treg transcription factor, FoxP3, and decreased suppressive function (Gerriets et al., 
2016; Huynh et al., 2015; Y. Park et al., 2013; Shrestha et al., 2015). Memory T cells return 
to an oxidative phenotype when they become quiescent, and like naïve T cells consume both 
glucose and lipids (Figure 1)(Phan et al., 2016; van der Windt et al., 2012). However, 
memory cells are metabolically distinct from naïve T cells in that they are poised to rapidly 
engage a program involving increased aerobic glycolysis upon re-encounter with antigens 
(Gubser et al., 2013; van der Windt et al., 2013).
Metabolic reprogramming in response to immune receptor stimulation is a common theme 
among many classes of immune cells in addition to lymphocytes. Stimulated macrophages 
and dendritic cells rapidly induce aerobic glycolysis following activation of pattern 
recognition receptors such as Toll-like receptors (TLRs) (O'Neill and E. J. Pearce, 2016). 
Thus, aerobic glycolysis is not restricted to proliferating immune cells and instead better 
associates with cells undergoing anabolic processes. For example, TLR-stimulated dendritic 
cells increase glycolysis to support new lipid synthesis for rapid expansion of the 
endoplasmic reticulum and Golgi, processes necessary for production and secretion of 
immune regulatory cytokines (Everts et al., 2014). Like T cell subsets, myeloid cells have 
functionally distinct phenotypes associated with different metabolic programs. Classically 
activated macrophages that promote inflammation utilize glycolysis and glutamine 
metabolism to generate large quantities of succinate that enhances inflammation and 
production of interleukin-1 (Tannahill et al., 2013). In contrast, macrophages that play a role 
in tissue healing and inflammatory resolution display more mitochondrial lipid oxidation 
(Vats et al., 2006). A key differentiator between these metabolic phenotypes may arise in the 
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mitochondria, where rather than engaging in conventional electron transport, altered electron 
flow through the succinate dehydrogenase complex promotes reactive oxygen species (ROS) 
generation and inflammation (Mills et al., 2016). Inhibition of respiration in myeloid cells as 
a consequence of nitric oxide production for host defense, may also be more tolerable 
because unlike antigen-specific lymphocytes, myeloid cells can be regenerated by the bone 
marrow if mitochondrial inhibition results in cell death (Brown and Borutaite, 2002; Everts 
et al., 2012). Macrophage metabolism has been recently reviewed in detail (Van den Bossche 
et al., 2017).
Ultimately, each immune cell metabolic phenotype is dependent on acquisition of 
appropriate nutrients. Indeed, forced expression of the glucose transporter Glut1 is 
associated with inflammatory T cells, and is sufficient to promote a systemic lupus 
erythematosus-like phenotype in transgenic mice (Michalek et al., 2011). Overexpression of 
Glut1 is also sufficient to increase the inflammatory character of macrophages (Freemerman 
et al., 2014). Conversely, Glut1-deficiency lowers glucose uptake and reduces T cell 
proliferation and inflammatory function in vivo. Tregs, in contrast, are less dependent on 
glucose metabolism and appear to function normally in the absence of Glut1 (Macintyre et 
al., 2014). Access to amino acids is also critical, as cells deficient in specific amino acid 
transporters fail to activate mTORC1 and induce T cell-mediated inflammation (Nakaya et 
al., 2014; Sinclair et al., 2013). Activation of mTORC1 can reprogram cell metabolism to 
support proliferation (Düvel et al., 2010), and by extension, the availability of amino acids 
and other nutrients in the microenvironment will have a profound impact on immune cell 
metabolism and function. Understanding the interplay between metabolism, immune subset 
differentiation and effector function requires a deeper understanding of how these various 
metabolic phenotypes support these functions and will shed light on how cells adapt to 
different physiological environments.
Oxygen, Oxidative Phosphorylation, and Aerobic Glycolysis
Most immune cell metabolic phenotypes are considered with respect to cellular energetics, 
including the manner by which cells produce ATP to support otherwise unfavorable 
reactions (Box 1). Oxidative cells produce a larger fraction of cellular ATP from 
mitochondrial oxidative phosphorylation, while glycolytic cells produce relatively more ATP 
from glycolysis. Some immune cells transition between oxidative and glycolytic metabolic 
phenotypes over the course of an immune response, and manipulation of this dichotomy can 
impact immunity. In exploring the importance of these metabolic phenotypes, it is helpful to 
recall the central importance of O2 in metabolism. Metazoan animal life is distinctly aerobic, 
and even brief interruptions in O2 supply can have profound effects on cellular function and 
viability. ATP production by either oxidative phosphorylation or glycolysis requires nutrient 
oxidation, i.e. removal of electrons from nutrients such as glucose (Vander Heiden and 
DeBerardinis, 2017)(Figure 1, Figure 2). Oxygen is the prototypic oxidizing agent, and its 
role as the terminal electron acceptor in the mitochondrial respiratory chain is generally 
appreciated. In addition, O2 is directly or indirectly required for numerous biochemical 
reactions (Goldfine, 1965; Raymond and Segrè, 2006). Oxygen is essential for the synthesis 
of sterols, unsaturated fatty acids, as well as the diverse biosynthetic, signaling, and 
epigenetic functions carried out by the large family of αKG-dependent dioxygenases 
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(Loenarz and Schofield, 2011). Within the immune system, O2 has a particularly important 
role in granulocyte ROS production for host defense (El-Benna et al., 2016; Mills et al., 
2016; West et al., 2011). The amount of O2 consumed by non-mitochondrial reactions can 
be physiologically significant (Banh et al., 2016).
Despite its central importance to metabolic phenotypes, O2 concentration is often an 
experimental unknown, and when it has been measured in vivo, technical considerations can 
influence measurement accuracy (Wilson, 2008). Oxygen concentration is linearly related to 
the partial pressure of O2 (pO2). In experiments performed in standard tissue culture 
conditions, media pO2 is near 145 mm Hg, or an O2 concentration of ∼200 μM. However, it 
has been estimated that the pO2 adjacent to an adherent cell monolayer can vary 
significantly, with reported values ranging from 0 mm Hg to greater than 100 mm Hg 
(Bambrick et al., 2011; Metzen et al., 1995; Wolff et al., 1993). The concentration of any 
metabolic substrate, including O2, is a balance between its rate of appearance and 
disappearance. As pertains to O2, this is a balance between O2 delivery and the oxygen 
consumption rate (OCR). In tissue culture, O2 delivery is determined by atmospheric 
conditions, media depth and aeration, and O2 diffusion. Oxygen consumption rate is 
determined by several factors discussed below, including cell number and metabolic state. 
Therefore, cells cultured in “normoxia” (i.e. unregulated atmospheric pO2) can in fact 
experience relative hypoxia if cells with high OCR are grown at high density. Conversely, 
cells with low OCR at low density can be exposed to supraphysiologic O2 concentrations in 
culture. In tissues, pO2 is tightly controlled within a narrow range, as O2 delivery via the 
vasculature is highly regulated (Duncker and Bache, 2008; Poole et al., 2013). Large 
contributors to O2 delivery include arterial oxygen content (CaO2), capillary density and 
blood flow, distance from the nearest blood vessel, and—importantly—tissue pO2 and as 
well as metabolic regulators of microvascular function and oxyhemoglobin unloading.
Oxygen delivery has perhaps been most studied in cardiac physiology. The heart extracts 
∼70% of the coronary CaO2 under basal conditions to support the high ATP needs of beating 
cardiomyocytes (Deussen et al., 2011). The coronary sinus, which drains the heart, is 
thought to be the most deoxygenated blood of the body with a pO2 near 20 mm Hg (Mik et 
al., 2009). This illustrates that the most aerobic organ of the body (gram-1) maintains a low 
tissue pO2 yet relies heavily on oxidative metabolism to maximize ATP production and carry 
out its physiological function for the organism. Thus, pO2 may not always be a good 
predictor of metabolic phenotype. This conclusion is supported by the fact that hypoxic stem 
cell microenvironments within the bone marrow are largely dependent on cellularity, i.e. low 
pO2 in the bone marrow is in part determined by the high O2 consumption of cells in those 
niches (Spencer et al., 2014). It has also been observed that O2 consumption by non-
mitochondrial dioxygenases can impact pO2 in poorly vascularized tumors (Banh et al., 
2016).
A common misconception is that the interdependence between pO2 on OCR is entirely 
reciprocal, and that pO2 directly determines the rate of cellular respiration and oxidative 
phosphorylation. In this view, aerobic glycolysis in proliferating cells is a paradox. The rate 
of oxidative phosphorylation is controlled by multiple variables in addition to pO2, including 
availability of oxidizable substrates, mitochondrial content, mitochondrial NAD+/NADH 
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ratio, pH, and cellular energy state  (Wilson, 2015; Wilson et al., 1974). ATP 
production is regulated to match ATP consumption, and all aspects of mitochondrial 
metabolism – TCA flux, NAD(H) metabolism, and respiration – are tightly coupled in most 
cells (Figure 2). It has been argued when pO2 becomes rate-limiting for mitochondrial 
respiration, the immediate decrease in cellular energy state and increased [ADP] can 
maintain mitochondrial respiratory rate (Wilson, 2015). Thus, reliance on pO2 alone to adapt 
metabolism to microenvironmental conditions has energetic and redox consequences, and 
cells have evolved additional means to adapt metabolism to hypoxia.
Cells sense pO2 via the EGLN (also called PHD) family of enzymes (Kaelin et al., 2016). 
These enzymes are α-ketoglutarate-dependent dioxygenases, with a Km for O2 >200 μM, 
well above tissue concentrations, making their enzymatic activity very responsive to changes 
in pO2 (Hirsilä et al., 2003). EGLNs hydroxylate the α-subunit of the hypoxia-inducible 
factor (HIFα), targeting this protein for degradation. HIF transcriptional activity is 
suppressed under conditions of high EGLN activity when O2 is present at sufficient 
concentration (Kaelin and Ratcliffe, 2008). A subset of HIF transcriptional targets increase 
glucose uptake and glycolysis, and actively inhibit pyruvate oxidation (Kim et al., 2006; 
Papandreou et al., 2006). These metabolic adaptations are predicted to (1) increase the 
contribution of substrate-level phosphorylation from glycolysis to ATP production, and (2) 
limit the reduction in mitochondrial NAD+/NADH ratio under hypoxia. These adaptations 
are important to decrease mitochondrial respiration and match O2 consumption to O2 
delivery, as they mitigate changes in energy state or mitochondrial NAD+/NADH ratio that 
might preserve respiratory rate at lower pO2. Additionally, decreased pyruvate oxidation 
under hypoxia might limit mitochondrial hyperpolarization and ROS production. Longer-
term, hypoxia and HIF stabilization impairs mitochondrial biogenesis (Zhang et al., 2007) 
and alters cellular cytochrome content (Fukuda et al., 2007), which can decrease total 
cellular respiratory capacity. Viewed from the perspective of a proliferating cell, the HIF 
metabolic program favors pyruvate reduction over oxidation, preserving NAD+/NADH ratio 
to facilitate oxidative biosynthesis when a major electron acceptor, O2, is in limited supply.
The importance of mitochondrial respiration in cellular energetics is more widely 
appreciated than the role of the respiratory chain in cellular redox homeostasis. Oxygen 
reduction to water is one of the primary outputs of the mitochondrial respiratory chain, and 
in certain contexts this function is more important than its role in ATP synthesis (Birsoy et 
al., 2015; Sullivan et al., 2015). For example, the ATP synthase inhibitor oligomycin blocks 
mitochondrial respiration and is toxic to cells; however, addition of an uncoupling agent that 
restores mitochondrial respiration (but not ATP production) can rescue both survival and 
proliferation in oligomycin-treated cells (Sullivan et al., 2015). Similarly, cells with genetic 
defects in mitochondrial respiration can survive and proliferate, but only if they are provided 
sufficient quantities of an alternative, practicable electron acceptor such as pyruvate (King 
and Attardi, 1989). Pyruvate reduction to lactate and O2 reduction to water both produce 
reduced products causing regeneration of the oxidized cofactor NAD+ from its reduced form 
NADH and facilitate electron disposal (Figure 2). While glycolysis can produce sufficient 
ATP to support cell proliferation, glycolysis is net redox-neutral. Therefore, glycolysis alone 
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cannot support the production of oxidized molecules needed for cell division, such as 
nucleotides (Figure 1). Mitochondrial respiration is therefore critical in all cells, even those 
exhibiting high rates of aerobic glycolysis (Joshi et al., 2015; Martínez-Reyes et al., 2015; 
Weinberg et al., 2010; Zu and Guppy, 2004). Interestingly, many cells with intact 
mitochondrial respiration proliferate faster in tissue culture when supplemented with excess 
pyruvate, which increases NAD+ regeneration from NADH. The tight correlation between 
cellular NAD+/NADH ratio, respiratory rate, and proliferation rate highlights the importance 
of electron acceptors in creation of new biomass during cell division (Gui et al., 2016; Titov 
et al., 2016). The low NAD+/NADH ratio associated with oxidative biosynthesis is one 
explanation for why many proliferating cell types use aerobic glycolysis (Vander Heiden and 
DeBerardinis, 2017).
Glucose is the most highly consumed fuel of proliferating cells, including cancer cells and 
proliferating lymphocytes. Glucose is needed to produce ribose used in nucleotide 
biosynthesis, glycolytic intermediates that contribute to amino acid metabolism, and 
NADPH via the oxidative pentose phosphate pathway (Lunt and Vander Heiden, 2011; 
Sagone et al., 1974). NADPH provides the cellular reducing potential for biosynthetic 
reactions such as cholesterol and lipid biosynthesis (Fan et al., 2014; Lewis et al., 2014), and 
is needed to maintain reduced glutathione, which has diverse functions in cellular redox 
homeostasis. However, in proliferating cells glucose contributes only ∼10% to cellular 
biomass, with most glucose converted to lactate in near equimolar amounts (Hosios et al., 
2016; Hume et al., 1978; Sagone et al., 1974). The fact that glucose is not a major carbon 
source for cell mass does not mean glycolysis is not important for proliferating cells. It has 
been argued that glycolytic ATP production provides metabolic flexibility to maintain 
energy state when OxPhos is limited by low pO2 in microenvironments such as the bone 
marrow or in a hypoxic tumor. It has also been argued that glycolysis permits faster ATP 
production than OxPhos (Koppenol et al., 2011), or that the decreased biosynthetic cost of 
producing glycolytic enzymes relative to OxPhos machinery is an advantageous energetic 
solution for proliferating cells (Shlomi et al., 2011). One certainty is that increased ATP 
production by glycolysis can decrease mitochondrial respiratory rate by increasing the 
cellular energy state. It should be noted that aerobic glycolysis is a common occurrence in 
normal physiology (Bulusu et al., 2017; Lindsay et al., 2014; Magistretti, 2016; O'Connor, 
1952), and it is estimated that the basal rate of lactate production in humans is 
approximately 1 mmol/kg/hr (Connor and Woods, 1982). Lactate is produced in conditions 
where pyruvate production exceeds the rate of pyruvate oxidation and cytosolic NAD+/
NADH is reduced. Pyruvate production can be increased by conditions that increase ATP 
consumption, such as exercise (James et al., 1999) or in response to high levels of catechols 
in sepsis (Garcia-Alvarez et al., 2016; Levy et al., 2005). In proliferating cells, growth 
factor-mediated increases in glucose uptake, high ATP consumption associated with cell 
growth, and low NAD+/NADH ratio secondary to oxidative biosynthesis can all contribute to 
increase lactate production and this may underlie the broad use of aerobic glycolysis in 
proliferating cells (Vander Heiden and DeBerardinis, 2017).
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Spare Respiratory Capacity
Differences in spare respiratory capacity (SRC) represent a prominent difference in 
metabolic phenotype among some immune cell subsets. Spare respiratory capacity is defined 
as the increase in OCR elicited by exposure to agents such as FCCP that uncouple 
mitochondrial O2 consumption from ATP production (Huang et al., 2014; van der Windt et 
al., 2012; 2001)(Figure 2). The existence of SRC requires that the cellular energy state 
 is sufficiently high that the demand for ATP synthesis is limiting the rate of 
electron transport (Figure 2). Thus, in cells with high SRC, OCR is limited by energy excess 
and not by substrate. The biological importance of SRC remains a source of debate. This 
phenotype may reflect a metabolic adaptation in some cells to increase their capacity for 
oxidative metabolism to produce ATP or for another process in which mitochondrial electron 
transport is required and may or may not be coupled to ATP synthesis (Sena et al., 2013).
Potential Biochemical Basis for Select Immune Cell Metabolic Phenotypes
We propose a model that incorporates principles of metabolic regulation to explain T cell 
phenotypes (Figure 3). Naïve T cells have few mitochondria as well as low ATP 
requirements to maintain homeostasis. Pyruvate production in a naïve T cell approximates 
the rate of pyruvate oxidation in the mitochondrial TCA cycle, and little lactate is produced. 
Following stimulation by foreign peptide-MHC and CD28 co-stimulation, T cells engage a 
proliferative program and their capacity for glucose uptake and pyruvate generation 
increases substantially, coincident with upregulation of genes encoding enzymes for 
glycolysis and the respiratory chain (Best et al., 2013; Jacobs et al., 2008). Demand for 
nucleotides and other oxidized biomass increases to support rapid cell proliferation, while 
the main process for disposing of electrons – cellular respiration – can be limited by low 
mitochondrial number and oxidation capacity, O2 availability, and/or a high energy state. 
This results in a lower cellular NAD+/NADH ratio, promoting pyruvate reduction to lactate. 
Thus, aerobic glycolysis reflects pyruvate production in excess of the cellular capacity for 
pyruvate oxidation, coupled with a low NAD+/NADH ratio. That is, lactate production in 
activated T cells is the result of the change in energetic, biosynthetic, and redox 
requirements of proliferation (Figure 1, Figure 2). This model incorporates the importance 
of cellular respiration in proliferation, and attributes high rates of lactate production to 
energetic excess, rather than energy deficiency. The model is consistent with observations 
that oligomycin-treated T cells can proliferate when excess glucose and pyruvate are 
available (Chang et al., 2013).
In a resolving immune response, T cell numbers contract and memory T cells are generated. 
Memory T cells are quiescent, non-dividing cells with a metabolic phenotype that is similar 
in many ways to naïve cells (Figure 1, Figure 3). However, these cells can proliferate and 
respond faster than naïve T cells following antigen exposure. They have increased capacity 
for protein synthesis to support proliferation and effector functions, and increased 
mitochondria with increased spare respiratory capacity. Thus, their capacity for ATP 
consumption, ATP generation, and nutrient oxidation are high despite low nutrient uptake, 
perhaps facilitating an ability to rapidly engage a proliferative program with increased 
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energetic and biosynthetic requirements. While the signaling events responsible for return to 
quiescence are poorly understood, it is clear that quiescence in central memory cells is 
maintained in part by low levels of glucose transporters; hence, the predominance of fatty 
acid oxidation in this T cell subset (Pan et al., 2017; van der Windt et al., 2013; van der 
Windt et al., 2012). In mammalian cells, fatty acids are unable to serve as an anaplerotic 
substrate for the TCA cycle to produce nucleotides and other biomass components, and the 
preference for this fuel may help limit proliferation until appropriate signals are provided to 
increase uptake of glucose and amino acids. Interestingly, forced maintenance of aerobic 
glycolysis during an immune response does not eliminate memory T cells, but instead 
creates an effector memory cell phenotype, highlighting the importance of fuel limitation in 
promoting memory cell quiescence (Phan et al., 2016). Regardless, baseline respiratory rate 
is higher in memory T cells than in naïve cells, reflecting reliance on fatty acid oxidation 
and OxPhos rather than glycolysis to make ATP. As occurs in naïve T cell activation, 
response of memory cells to full antigen receptor stimulation activates a proliferative 
metabolic program with increased glucose uptake, increased nucleotide production (with a 
fall in NAD+/NADH ratio), and higher lactate production. Thus, the increased oxidative 
capacity afforded by the high mitochondrial mass in memory T cells as compared to a 
proliferating naïve T cell may facilitate production of nucleotides and oxidized biomass that 
can be limiting for cell proliferation (Vander Heiden and DeBerardinis, 2017) and enable 
rapid clonal expansion when memory cells encounter antigen.
The capacity of a cell to oxidize fuels is intimately linked to its ability to perform effector 
functions and proliferate. As discussed above, quiescence in T cell subsets is associated with 
low levels of glucose transporters, while productive antigen-receptor stimulation is linked to 
transporter upregulation and increased glucose uptake. In this way, access to oxidizable 
nutrients is coordinated with metabolic demands to support proliferation. Similarly, imposed 
suppression of T cell oxidative capacity are coincident with active T cell suppression. In 
chronic immune responses such as occur in chronic infections or cancer, a phenomenon 
known as T cell exhaustion (Tex) occurs, associated with expression of the inhibitory co-
receptor PD-1 and blunted effector functions (Bengsch et al., 2016; Wherry and Kurachi, 
2015). In Tex cells, cellular capacity for nutrient oxidation is limited by both low levels of 
glucose transporters and altered mitochondria (Figure 3). Blockade of PD-1 – PDL1 binding 
can reverse this metabolic program and restore anti-tumor immunity (Bengsch et al., 2016). 
A similar phenomenon has been observed in tumor-infiltrating and tumor-associated 
lymphocytes (TILs) (Scharping et al., 2016). T cells isolated from patients and preclinical 
models with B cell leukemia are also exhausted, and have low rates of glucose uptake and 
glycolysis. Restoration of glucose uptake can partially restore T cell activity demonstrating 
that cancer-induced T cell metabolic impairments contribute to poor T cell function (Siska et 
al., 2016). Mitochondrial dysfunction also appears to play a key role in reduced TIL function 
as improved mitochondrial biogenesis and quality control could enhance anti-tumor 
immunity (Chamoto et al., 2017; Scharping et al., 2016) and T cells with low mitochondrial 
potential had greater ability to eliminate tumors in adoptive cell therapy (Sukumar et al., 
2016). Indeed, regulation of mitochondrial quality control may contribute to T cell longevity 
and generation of immunological memory (Adams et al., 2016).
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In the interpretation of T cell metabolic phenotypes provided, aerobic glycolysis as a 
characteristic of immune cell activation supports both ATP production and oxidative 
biosynthesis in these cells. A high rate of glycolytic ATP production may also provide other 
immune cells the flexibility to use O2 for purposes other than energetics. Macrophages 
display a variety of metabolic phenotypes (Van den Bossche et al., 2017). Oxygen can be a 
limited resource in immune cell microenvironments and mitochondrial respiration is likely 
the largest O2 consumer by many immune cells. Nevertheless, decreased reliance on OxPhos 
could enable increased activity of non-mitochondrial oxidases involved in biosynthesis or 
epigenetic regulation, both critically important for the function of numerous immune cell 
subsets. Similarly, production of ROS by some immune cells is critical for host defense and 
may also be facilitated by a more glycolytic phenotype. Production of ATP by glycolysis and 
inhibiting ATP synthase to facilitate mitochondrial hyperpolarization will preserve O2 
availability as well as promote non-mitochondrial oxidase activity such as NOX (Mills et al., 
2016). Lactate production will also be increased in conjunction with a more reduced cell 
state that favors ROS generation. Using glycolysis to maintain energy state has the added 
benefit of providing a pyruvate “buffer” to maximize biochemical flexibility. Provided 
glycolysis maintains energy state, uncoupling of mitochondrial respiration from ATP 
production can facilitate oxidation of phagocytosed material, (D. Park et al., 2011). In 
summary, immune cell activation generates a change in energetic and redox state. 
Maintenance of energy state by glycolysis and generation of a pyruvate “buffer” provides 
maximal biochemical flexibility for cells to adapt to this change in state.
This model attempts to explain immune cell metabolic phenotypes in relation to biochemical 
requirements of cell functions, and extends beyond ATP production as the only output of 
metabolism. All immune cell functions require ATP, whether it be production of new 
biomass and cytokines in a proliferating lymphocyte, antibody production in B cells, 
pathogen destruction, or oxidation of ingested biomass in phagocytes. The pathways used to 
generate the ATP may be a secondary consequence, and oxidative to glycolytic metabolic 
reprogramming might reflect biochemical requirements other than energetics. Many details 
of this model are untested; however, the model is consistent with data in other cell systems 
and generally consistent with principles of cellular energetics. The model highlights a few 
important points. First, the terminology used to describe metabolic phenotypes can be 
confusing (Box 1). Cells are described as “oxidative” when pyruvate production 
approximates pyruvate oxidation and “glycolytic” when lactate is produced. However, the 
rate of pyruvate oxidation and mitochondrial respiratory rate of a “glycolytic” proliferating 
T cells often exceeds the rate observed in a naïve T cell given the higher total rate of nutrient 
uptake (Guppy et al., 1993; Hume et al., 1978). Describing metabolic programs as either 
oxidative or glycolytic simplifies a complex relationship between cellular respiratory 
capacity, cellular redox requirements, cellular energetics, and fuel availability. Similarly, the 
presence or absence of spare respiratory capacity as a common phenotype in several immune 
cell subsets has been a source of confusion to many readers. Spare respiratory capacity is the 
magnitude of respiration increase following treatment of cells with FCCP or another drug 
that uncouples respiration from ATP production. Spare respiratory capacity, therefore, 
reflects a similarly complex relationship between total respiratory capacity and cellular 
energetics. Elucidating the underlying biochemical basis of many immune cell metabolic 
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phenotypes can be challenging; however, as therapies targeting immunometabolism continue 
to show efficacy in altering immunity, improving this understanding might aid in the design 
of more effective therapeutics.
Influence of Available Nutrients on Immune Cell Metabolism
Accumulating data suggest that the microenvironment can have a profound effect on 
immune cell function (Chang and E. L. Pearce, 2016). Dissecting how tissue environment 
affects immunometabolism can be challenging, because the conditions of nutrient excess 
used to culture cells in vitro are quite different from the microenvironment experienced by 
cells in tissues (Mayers and Vander Heiden, 2015). A prominent example is the nutrient 
limitations immune cells experience within the tumor microenvironment, where poor 
vascular supply and high nutrient consumption by cancer cells combine to deplete available 
nutrients. It has been estimated that glucose is ∼10-fold lower in the tumor interstitium than 
it is in the plasma. T cells can adapt to low glucose by increasing glutamine metabolism 
(Blagih et al., 2015), but low glucose levels within a tumor alters tumor-infiltrating 
lymphocytes (TILs) metabolism and effector function and represents a metabolic mechanism 
by which cancer cells can escape immune surveillance (Chang et al., 2013; Chang et al., 
2015; Ho et al., 2015). In a glucose-poor environment, the decreased amount of glucose 
available to TILs leads to lower levels of glycolytic intermediates including 
phosphoenolpyruvate (PEP), which alters T cell receptor (TCR)-mediated calcium flux and 
T cell activation. Interestingly, this microenvironmental limitation can be overcome by 
genetic manipulation of enzyme expression to artificially raise PEP levels, providing proof-
of-principle that modulating immune cell metabolism can directly influence immune 
responses (Ho et al., 2015). Therapies that result in lower tumor cell glucose consumption 
might work in part by altering environmental conditions within the tumor to better support 
TIL function (Chang et al., 2015). Similarly, the accumulation of metabolic products in the 
tumor microenvironment has important implications, such as the influence of high lactate 
concentration in tumors on macrophage polarization (Carmona-Fontaine et al., 2017; 
Colegio et al., 2014). Finally, immune cell function can also be limited by amino acid 
availability. The observation that guinea pig serum could inhibit the growth of a murine 
lymphoma led to the purification of asparaginase as an anti-neoplastic enzymatic activity 
that was later found to also inhibit the growth of normal lymphocytes (Berenbaum, 1970; 
Broome, 1963; Kidd, 1953a; Kidd, 1953b). Environmental limitations of asparagine, 
tryptophan, serine (Ma et al., 2017), and arginine have all been demonstrated to impact 
immune cell function under various conditions in vivo. The extensive literature studying 
amino acid deficiency on immune cell function has been recently reviewed elsewhere 
(Murray, 2016).
Oxygen can be another limited resource for immune cells in in vivo. While circulating 
immune cells are exposed to the O2 concentration of blood (∼75-100 mm Hg or ∼100-140 
μM), the pO2 of tissues is much lower, on average approaching the mixed venous pO2 of 
35-50 mm Hg. In the bone marrow, pO2 measurements vary among microenvironmental 
niches, with a range between 10-22 mm Hg (Spencer et al., 2014). A similar range of pO2 
has been reported in the spleen, whereas the pO2 in the thymus is lower, closer to 10 mm Hg 
(Braun et al., 2001). Cho et al. recently demonstrated that germinal centers have regional 
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variations in pO2, with important consequences for B cell biology (Cho et al., 2016). In a 
tumor, pO2 varies based on radial and longitudinal distance from the arterial supply, with 
areas that are well-oxygenated and other areas that are anoxic (Koch and Evans, 2015). 
While pO2 is in part dependent on OCR of cells in those niches, hypoxia responses are 
observed in immune cells in vivo, providing physiologic evidence of O2 limitation (Cho et 
al., 2016). Hypoxia and inflammation are intimately connected (Eltzschig and Carmeliet, 
2011). Tissue hypoxia leads to inflammation, and high O2 consumption by inflammatory 
cells can lead to hypoxia. HIF transcriptional activity been demonstrated to play an 
important role in macrophage subsets (Colegio et al., 2014; Cramer et al., 2003), in B cell 
class-switching (Cho et al., 2016), CD8+ T cell differentiation (Doedens et al., 2013; Tyrakis 
et al., 2016), and in determining the balance of Th17 and Treg cell differentiation (Dang et 
al., 2011; Shi et al., 2011). HIF has many transcriptional targets that are not directly involved 
in metabolism including epigenetic modifiers and transcription factors such as NF-κB and 
RORγt, which have established roles in immunity (Schödel et al., 2011). Whether the 
metabolic effects of HIF are critical to support the biochemical needs of cell differentiation 
or immune effector functions remains an open question. Given the importance of 
mitochondrial respiration for cell proliferation, and the importance of non-mitochondrial 
respiration in innate immunity, it is tempting to speculate that O2 might be a limiting 
nutrient at sites of immune cell activation and influence the character and magnitude of 
immune responses.
Conclusions
The biochemical requirements of cell biology and physiology have been an active area of 
research for more than a century. Technologic advances have increased our ability to 
describe metabolic phenotypes, but we still rely on the lens of core biochemical principles to 
understand the complexity underlying differences in cell metabolism. This review has 
considered immune cell metabolic phenotypes within the context of the energetic and redox 
requirements of immune cell function. Many of the models and assumptions proposed are 
untested, and observations based on in vitro studies will require validation in vivo. Changes 
in metabolite levels can also directly affect cell state (Tyrakis et al., 2016), and as new 
observations are made about the interdependence of immune cell metabolism and function, 
contextualizing those findings within core principles of biochemistry and physiology will be 
important to understand their role in host defense and exploit these relationships for patient 
benefit.
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Box 1
Terminology
Term Common Definition Considerations
Oxidative Cell A cell that converts most 
of the consumed glucose to 
CO2 in the mitochondrial 
TCA cycle.
The distinguishing feature of a glycolytic cell is 
lactate production. Glycolytic cells still rely on 
oxidative TCA cycle flux and mitochondrial 
respiration. In fact, O2 consumption can be 
higher in glycolytic cells as compared to 
‘oxidative’ quiescent cells, as total nutrient 
uptake is increased. Fuel oxidation is required 
for survival of all cells, and both pyruvate 
reduction to lactate and O2 reduction to water 
enable fuel oxidation.
Glycolytic Cell A cell that converts most 
of the consumed glucose to 
lactate.
Aerobic glycolysis High rate of lactate 
production from glucose 
despite normoxia.
A high rate of lactate production does not mean 
that mitochondrial respiration is necessarily 
suppressed. SRC implies that O2 consumption is 
less than maximum, possibly because a high 
energy state limits use of the proton gradient to 
drive ATP synthesis. The total respiratory 
capacity of a cell is a measure of the capacity of 
cells to make ATP via oxidative 
phosphorylation, but also the capacity for fuel 
oxidation and NADH recycling. Cells with SRC 
can increase nutrient oxidation if demands for 
either ATP or biomass increase provided 
nutrients remain available.
Spare Respiratory 
Capacity (SRC)
SRC is the difference 
between the cellular O2 
consumption rate (OCR), 
and the OCR after cells are 
treated with an uncoupling 
agent that disrupts the 
mitochondrial proton 
gradient and allows 
maximal O2 consumption.
Energy State Energy state regulates mitochondrial respiratory 
rate. Increased ATP production from aerobic 
glycolysis can decrease mitochondrial 
respiration by increasing the energy state. This 
interdependence of glycolysis and mitochondrial 
respiration has been referred to as the Crabtree 
Effect, although some authors have objected to 
this term as the Crabtree Effect is caused by 
depletion of inorganic phosphate.
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Figure 1. The metabolic phenotype of quiescent and activated T cells
Quiescent T cells including naïve and memory cells exhibit a more oxidative metabolic 
phenotype characterized by low nutrient uptake and minimal lactate production. In contrast, 
activated T cells utilize aerobic glycolysis with increased glucose uptake and lactate 
production. Activated T cells still oxidize glucose in the mitochondrial TCA cycle, and the 
rate of glucose oxidation in activated T cells can be greater than that found in quiescent T 
cells. These different metabolic phenotypes may reflect the different metabolic requirements 
of these different cell states. Quiescent T cells oxidize limiting nutrients to maintain energy 
state and promote cell survival, while activated T cells alter metabolism to support cell 
proliferation and effector functions. The increased demand for synthesizing nucleotides and 
other oxidized biomass in proliferating cells results in a lower NAD+/NADH ratio and 
contributes to increased lactate production.
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Figure 2. Relationship between glycolysis, oxygen consumption, ATP production and redox 
metabolism
Glycolysis and mitochondrial respiration both supply cellular ATP. Production of lactate 
from pyruvate allows NAD+ regeneration and maintenance of redox balance for glycolysis. 
Redox balance is maintained when pyruvate or fatty acids from lipids are oxidized in the 
mitochondrial TCA cycle by transfer of electrons to O2 via the electron transport chain. 
When O2 consumption is coupled to ATP production, the proton (H+) gradient across the 
inner mitochondrial membrane generated by the electron transport chain is used to drive 
ATP synthesis (oxidative phosphorylation). Oxygen consumption can also be uncoupled 
from ATP production if there is another route for protons to cross the inner mitochondrial 
membrane (uncoupled respiration). This can occur via endogenous uncoupling proteins or 
via pharmacologic agents such as FCCP that are used to assess spare respiratory capacity. 
Production of lactate or consumption of O2 at rates that are stoichiometric with nutrient 
oxidation is necessary for electron disposal and redox homeostasis in cell metabolism.
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Figure 3. Model relating metabolic state of different T cell subsets to cell function
Naïve T cells exhibit low glucose transporter expression and nutrient uptake, with 
metabolism directed toward nutrient oxidation and cell survival. Nutrient uptake and 
mitochondrial mass are increased upon T cell activation, facilitating the production of new 
biomass for proliferation. Memory T cells return to a low nutrient uptake state, again relying 
on nutrient oxidation to support cell survival; however, these cells retain more mitochondria 
(oxidation capacity) facilitating their ability to re-engage a proliferative program when 
reactivated. Exhausted T cells become limited for nutrient uptake and/or oxidizing capacity 
secondary to dysfunctional mitochondria limiting their ability to support a proliferative 
metabolic program.
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